Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methoxyflurane via mask versus inhaler for acute limb trauma pain
2022-002944-40Phase 4Completed
- Sponsor
- CHU Brugmann
- Start
- Jan 2023
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of methoxyflurane in acute pain (2 arms), sponsored by CHU Brugmann. Primary endpoint: Primary pain intensity reduction. Started Jan 2023; status: completed.
02
Drugs
methoxyflurane
03
Conditions
acute pain
Beyond the preview
Go deeper on 2022-002944-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-002944-40.